These beneficial cellular responses position PIKfyve as a potential therapeutic target for disorders characterized by lysosomal dysfunction, particularly neurodegenerative diseases where failure of lysosomes to clear protein aggregates is a key feature. Here, PIKFYVE is linked to neurodegenerative disease.